ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹242 Cr | ₹196 Cr | ₹215 Cr | ₹171 Cr | ₹136 Cr |
What is the latest Sundry Debtors ratio of ORCHID PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹242 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹215 Cr |
| Mar2022 | ₹171 Cr |
| Mar2021 | ₹136 Cr |
How is Sundry Debtors of ORCHID PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹242 Cr | 23.67 | |
| Mar2024 | ₹196 Cr | -9.13 | |
| Mar2023 | ₹215 Cr | 26.16 | |
| Mar2022 | ₹171 Cr | 25.70 | |
| Mar2021 | ₹136 Cr | - | |
Compare Sundry Debtors of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,589.6 Cr | -0.7% | 28.1% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -0.7% |
28.1% |
-6.9% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses